Physician profile
Amy Hellman
NPI 1437386042
$1,551.07
in general payments reported to CMS, 2019-2025
13 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $259 · 2023: $190 · 2024: $587 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $440.86 | 2021-2025 | Aveir, Jot Dx |
| Medtronic, INC. | $305.87 | 2022-2025 | Aurora Ev-Icd Mri Surescan, Azure Xt Dr Mri Surescan, Mycarelink |
| Pfizer INC. | $276.52 | 2021-2025 | |
| Boston Scientific Corporation | $256.62 | 2023-2025 | Watchman Flx, General - Therapies, Farapulse |
| Janssen Pharmaceuticals, INC | $64.82 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $62.30 | 2024 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $38.43 | 2021-2024 | |
| Baxter Healthcare | $29.80 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Impulse Dynamics (USA) INC. | $18.75 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.00 | 2023 | Lifevest |
| Biosense Webster, INC. | $15.97 | 2021 | |
| Kerecis Limited | $12.07 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Edwards Lifesciences Corporation | $11.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Hellman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.